GB0306070D0 - Organic compounds - Google Patents

Organic compounds

Info

Publication number
GB0306070D0
GB0306070D0 GB0306070A GB0306070A GB0306070D0 GB 0306070 D0 GB0306070 D0 GB 0306070D0 GB 0306070 A GB0306070 A GB 0306070A GB 0306070 A GB0306070 A GB 0306070A GB 0306070 D0 GB0306070 D0 GB 0306070D0
Authority
GB
United Kingdom
Prior art keywords
organic compounds
compounds
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0306070A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Priority to GB0306070A priority Critical patent/GB0306070D0/en
Publication of GB0306070D0 publication Critical patent/GB0306070D0/en
Priority to ARP040100730A priority patent/AR043504A1/en
Priority to TW093106848A priority patent/TW200503703A/en
Priority to PE2004000273A priority patent/PE20050313A1/en
Priority to TW097116133A priority patent/TW200835484A/en
Priority to EP04720871A priority patent/EP1608368B8/en
Priority to AT04720871T priority patent/ATE409479T1/en
Priority to US10/547,185 priority patent/US20060154952A1/en
Priority to CN 200480005834 priority patent/CN1756548A/en
Priority to PCT/EP2004/002714 priority patent/WO2004082681A1/en
Priority to MYPI20040914A priority patent/MY137868A/en
Priority to MXPA05009934A priority patent/MXPA05009934A/en
Priority to JP2005518678A priority patent/JP2006515017A/en
Priority to DE602004016830T priority patent/DE602004016830D1/en
Priority to BRPI0408423-3A priority patent/BRPI0408423A/en
Priority to CA002633287A priority patent/CA2633287A1/en
Priority to AU2004222563A priority patent/AU2004222563B2/en
Priority to PT04720871T priority patent/PT1608368E/en
Priority to RU2005131996/15A priority patent/RU2005131996A/en
Priority to PL04720871T priority patent/PL1608368T3/en
Priority to ES04720871T priority patent/ES2315648T3/en
Priority to CL200400535A priority patent/CL2004000535A1/en
Priority to CA002517671A priority patent/CA2517671A1/en
Priority to KR1020057017469A priority patent/KR100855140B1/en
Priority to ZA200506372A priority patent/ZA200506372B/en
Priority to TNP2005000197A priority patent/TNSN05197A1/en
Priority to EC2005006006A priority patent/ECSP056006A/en
Priority to HR20050800A priority patent/HRP20050800A2/en
Priority to IS8028A priority patent/IS8028A/en
Priority to MA28526A priority patent/MA27671A1/en
Priority to NO20054778A priority patent/NO20054778L/en
Priority to HK06106761.8A priority patent/HK1086743A1/en
Ceased legal-status Critical Current

Links

GB0306070A 2003-03-17 2003-03-17 Organic compounds Ceased GB0306070D0 (en)

Priority Applications (32)

Application Number Priority Date Filing Date Title
GB0306070A GB0306070D0 (en) 2003-03-17 2003-03-17 Organic compounds
ARP040100730A AR043504A1 (en) 2003-03-17 2004-03-08 PHARMACEUTICAL COMPOSITIONS THAT INCLUDE RAPAMYCIN FOR THE TREATMENT OF INFLAMMATORY DISEASES
TW093106848A TW200503703A (en) 2003-03-17 2004-03-15 Pharmaceutical compositions
PE2004000273A PE20050313A1 (en) 2003-03-17 2004-03-15 PHARMACEUTICAL COMPOSITION INCLUDING A COMBINATION OF RAPAMYCIN OR ITS DERIVATIVE AND PIMECROLIMUS
TW097116133A TW200835484A (en) 2003-03-17 2004-03-15 Use of a combination of rapamycin or its derivative and pimecrolimus
KR1020057017469A KR100855140B1 (en) 2003-03-17 2004-03-16 Pharmaceutical compositions comprising a combination of rapamycin or its derivative and pimecrolimus for the treatment of inflammation- and immunologically-mediated diseases
BRPI0408423-3A BRPI0408423A (en) 2003-03-17 2004-03-16 pharmaceutical compositions comprising a combination of rapamycin or derivatives thereof and pimecrolimus for the treatment of immunologically and inflammatory mediated diseases
RU2005131996/15A RU2005131996A (en) 2003-03-17 2004-03-16 PHARMACEUTICAL COMPOSITIONS CONTAINING THE COMBINATION OF RAPAMICINE OR ITS DERIVATIVE AND PIMECROLIMUS FOR THE TREATMENT OF INFLAMMATORY AND IMMUNO-MEDIATED DISEASES
US10/547,185 US20060154952A1 (en) 2003-03-17 2004-03-16 Pharmaceutical compositions comprising a combination of rapamycin or its derivative and pimecrolimus for the treatment of inflammation-and ummunologically-mediated diseases
CN 200480005834 CN1756548A (en) 2003-03-17 2004-03-16 Pharmaceutical compositions comprising a combination of rapamycin or its derivative and pimecrolimus for the treatment of inflammation- and ummunologically-mediated diseases
PCT/EP2004/002714 WO2004082681A1 (en) 2003-03-17 2004-03-16 Pharmaceutical compositions comprising a combination of rapamycin or its derivative and pimecrolimus for the treatment of inflammation- and ummunologically-mediated diseases
MYPI20040914A MY137868A (en) 2003-03-17 2004-03-16 Pharmaceutical compositions comprising a combination of rapamycin or its derivative and pimecrolimus for the treatment of inflammation and ummunologically-mediated diseases
MXPA05009934A MXPA05009934A (en) 2003-03-17 2004-03-16 Pharmaceutical compositions comprising a combination of rapamycin or its derivative and pimecrolimus for the treatment of inflammation- and ummunologically-mediated diseases.
JP2005518678A JP2006515017A (en) 2003-03-17 2004-03-16 Pharmaceutical composition comprising a combination of rapamycin or a derivative thereof and pimecrolimus for the treatment of inflammatory and immune mediated diseases
DE602004016830T DE602004016830D1 (en) 2003-03-17 2004-03-16 PHARMACEUTICAL COMPOSITIONS COMPRISING A COMBINATION OF RAPAMYCIN OR ITS DERIVATIVES AND PIMECROLIMUS FOR THE TREATMENT OF INFLAMMATORY ENTIRE DISEASE (IBD)
EP04720871A EP1608368B8 (en) 2003-03-17 2004-03-16 Pharmaceutical compositions comprising a combination of rapamycin or its derivative and pimecrolimus for the treatment of inflammatory bowel disease (ibd)
CA002633287A CA2633287A1 (en) 2003-03-17 2004-03-16 Combinations of rapamycin or its derivatives and pimecrolimus for the treatment of inflammation- and immunologically-mediated diseases
AU2004222563A AU2004222563B2 (en) 2003-03-17 2004-03-16 Pharmaceutical compositions comprising a combination of rapamycin or its derivative and pimecrolimus for the treatment of inflammation- and immunologically-mediated diseases
PT04720871T PT1608368E (en) 2003-03-17 2004-03-16 Pharmaceutical compositions comprising a combination of rapamycin or its derivative and pimecrolimus for the treatment of inflammatory bowel disease (ibd)
AT04720871T ATE409479T1 (en) 2003-03-17 2004-03-16 PHARMACEUTICAL COMPOSITIONS CONTAINING A COMBINATION OF RAPAMYCIN OR ITS DERIVATIVES AND PIMECROLIMUS FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE (IBD)
PL04720871T PL1608368T3 (en) 2003-03-17 2004-03-16 Pharmaceutical compositions comprising a combination of rapamycin or its derivative and pimecrolimus for the treatment of inflammatory bowel disease (ibd)
ES04720871T ES2315648T3 (en) 2003-03-17 2004-03-16 PHARMACEUTICAL COMPOSITIONS THAT INCLUDE A COMBINATION OF RAPAMYCIN OR ITS DERIVATIVE AND PIMECROLIMUS FOR THE TREATMENT OF THE INFLAMMATORY DISEASE OF THE INTESTINE (IBD).
CL200400535A CL2004000535A1 (en) 2003-03-17 2004-03-16 PHARMACEUTICAL COMPOSITION THAT INCLUDES RAPAMYCIN OR A DERIVATIVE OF RAPAMYCIN AND PIMECROLIMUS; AND ITS USE FOR THE TREATMENT OF INFLAMMATORY DISEASE OF THE INTESTINE.
CA002517671A CA2517671A1 (en) 2003-03-17 2004-03-16 Combinations of rapamycin or its derivatives and pimecrolimus for the treatment of inflammation- and immunologically-mediated diseases
ZA200506372A ZA200506372B (en) 2003-03-17 2005-08-10 Pharmaceutical compositions comprising a combination of rapamycin or its derivative and pimecroliums for the treatment of inflammation- and immunologically-mediated diseases
TNP2005000197A TNSN05197A1 (en) 2003-03-17 2005-08-17 Pharmaceutical compositions comprising a combination of rapamycin or its derivative and pimecrolimus for the treatment of inflammation -and immunologically- mediated diseases
EC2005006006A ECSP056006A (en) 2003-03-17 2005-09-08 PHARMACEUTICAL COMPOSITIONS THAT INCLUDE A COMBINATION OF RAPAMYCIN OR ITS DERIVATIVE AND PIMECROLIMUS FOR THE TREATMENT OF INFLAMMATORY AND IMMUNOLOGICALLY MEDIATED DISEASES
HR20050800A HRP20050800A2 (en) 2003-03-17 2005-09-12 Pharmaceutical compositions comprising a combination of rapamycin or its derivative and pimecrolimus for the treatment of inflammation- and immunologically-mediated diseases
IS8028A IS8028A (en) 2003-03-17 2005-09-15 Medicinal preparations comprising the composition or derivative of rapamycin and pimecrolimus for the treatment of inflammatory and immune-mediated diseases
MA28526A MA27671A1 (en) 2003-03-17 2005-09-30 PHARMACEUTICAL COMPOSITIONS COMPRISING A COMBINATION OF RAPAMYCIN OR DERIVATIVE THEREOF AND PIMECROLIMUS FOR THE TREATMENT OF INFLAMMATORY AND IMMUNOLOGICALLY INDUCED DISEASES
NO20054778A NO20054778L (en) 2003-03-17 2005-10-17 Pharmaceutical compositions including a combination of rapamycin or its derivative and pimecrolimus for the treatment of inflammatory and immunologically mediated diseases
HK06106761.8A HK1086743A1 (en) 2003-03-17 2006-06-13 Pharmaceutical compositions comprising a combination of rapamycin or its derivative and pimecrolimus for the treatment of inflammatory bowel disease (ibd)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0306070A GB0306070D0 (en) 2003-03-17 2003-03-17 Organic compounds

Publications (1)

Publication Number Publication Date
GB0306070D0 true GB0306070D0 (en) 2003-04-23

Family

ID=9954921

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0306070A Ceased GB0306070D0 (en) 2003-03-17 2003-03-17 Organic compounds

Country Status (3)

Country Link
CN (1) CN1756548A (en)
GB (1) GB0306070D0 (en)
ZA (1) ZA200506372B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105663027B (en) * 2016-04-01 2018-12-18 中国人民解放军***武汉总医院 Sirolimus external preparation, preparation method and the usage

Also Published As

Publication number Publication date
CN1756548A (en) 2006-04-05
ZA200506372B (en) 2006-07-26

Similar Documents

Publication Publication Date Title
GB0301259D0 (en) Organic compounds
GB0303503D0 (en) Organic compounds
GB0306715D0 (en) Organic compounds
GB0307553D0 (en) Organic compounds
GB0307856D0 (en) Organic compounds
GB0302876D0 (en) Organic compounds
GB0307860D0 (en) Organic compounds
GB0300095D0 (en) Organic compounds
GB0301938D0 (en) Organic compounds
GB0301471D0 (en) Organic compounds
GB0302748D0 (en) Organic compounds
GB0303506D0 (en) Organic compounds
GB0307440D0 (en) Organic compounds
GB0306070D0 (en) Organic compounds
GB0302991D0 (en) Organic compounds
GB0306071D0 (en) Organic compounds
GB0307277D0 (en) Organic compounds
GB0302874D0 (en) Organic compounds
GB0316086D0 (en) Organic compounds
GB0301262D0 (en) Organic compounds
GB0308009D0 (en) Organic compounds
GB0307870D0 (en) Organic compounds
GB0300910D0 (en) Organic compounds
GB0307858D0 (en) Organic compounds
GB0300590D0 (en) Organic compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)